Guangzhou Medprin Regenerative Medical Technologies announced that its research and development project, Absorbable Hemostatic Fluid Gelatin, has officially entered the clinical trial stage. The product is a Class III medical device used to assist hemostasis during surgical procedures. The company stated that this move will help enrich its product line in other surgical fields, but there are uncertainties in clinical trials and regulatory approval for market launch, and it is currently unable to predict the impact on its financial performance.
Medprin Regenerative Medical Technologies Co. Ltd.Medprin's Absorbable Hemostatic Fluid Gelatin R&D project entered clinical trial stage, advancing its Class III medical device pipeline.
